WEST PHARMACEUTICAL SERVICES, INC. Payments for Restructuring
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Payments for Restructuring of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2026-02-17
- WEST PHARMACEUTICAL SERVICES, INC. payments for restructuring for the quarter ending 2025-12-31 was -$7.60M.
- WEST PHARMACEUTICAL SERVICES, INC. payments for restructuring for the quarter ending 2025-09-30 was $400.00K.
- WEST PHARMACEUTICAL SERVICES, INC. payments for restructuring for the quarter ending 2025-06-30 was $2.70M.
- WEST PHARMACEUTICAL SERVICES, INC. payments for restructuring for the quarter ending 2025-03-31 was $4.50M.
- WEST PHARMACEUTICAL SERVICES, INC. payments for restructuring for fiscal 2025 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. payments for restructuring for fiscal 2017 was $3.10M, a 3.33% increase from fiscal 2016.
- WEST PHARMACEUTICAL SERVICES, INC. payments for restructuring for fiscal 2016 was $3.00M.
- WEST PHARMACEUTICAL SERVICES, INC. payments for restructuring for fiscal 2013 was $2.80M, a 30.00% decline from fiscal 2012.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month | Payments for Restructuring 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$7.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$7.20M derived: sum of 2 quarters · filed 2026-02-17 | -$4.50M derived: sum of 3 quarters · filed 2026-02-17 | $0.00 10-K · filed 2026-02-17 |
| 2025-09-30 | $400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | $3.10M derived: sum of 2 quarters · filed 2025-10-23 | $7.60M 10-Q · filed 2025-10-23 | |
| 2025-06-30 | $2.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-24 | $7.20M 10-Q · filed 2025-07-24 | ||
| 2025-03-31 | $4.50M 10-Q · filed 2025-04-24 | |||
| 2024-09-30 | $500.00K 10-Q · filed 2024-10-24 | |||
| 2017-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $1.40M derived: sum of 2 quarters · filed 2018-02-26 | $2.00M derived: sum of 3 quarters · filed 2018-02-26 | $3.10M 10-K · filed 2018-02-26 |
| 2017-09-30 | $1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $1.80M derived: sum of 2 quarters · filed 2017-10-31 | $2.90M 10-Q · filed 2017-10-31 | $4.30M derived: sum of 4 quarters · filed 2018-02-26 |
| 2017-06-30 | $600.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $1.70M 10-Q · filed 2017-08-01 | $3.10M derived: sum of 3 quarters · filed 2018-02-26 | $4.00M derived: sum of 4 quarters · filed 2018-02-26 |
| 2017-03-31 | $1.10M 10-Q · filed 2017-05-05 | $2.50M derived: sum of 2 quarters · filed 2018-02-26 | $3.40M derived: sum of 3 quarters · filed 2018-02-26 | $3.40M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $2.30M derived: sum of 2 quarters · filed 2018-02-26 | $2.30M derived: sum of 3 quarters · filed 2018-02-26 | $3.00M 10-K · filed 2018-02-26 |
| 2016-09-30 | $900.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-31 | $900.00K derived: sum of 2 quarters · filed 2016-10-31 | $1.60M 10-Q · filed 2016-10-31 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01 | $700.00K 10-Q · filed 2016-08-01 | ||
| 2016-03-31 | $700.00K 10-Q · filed 2016-05-06 | |||
| 2013-12-31 | $2.80M 10-K · filed 2014-02-27 | |||
| 2012-12-31 | $4.00M 10-K · filed 2014-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |